History has shown differently davidc. After recent SPP's the price has risen rather well on rumor and sold on the shabby phase 2a trial fact. If that bit of 'dermception' hadn't taken place, we would be mellowing out about 7 cents now.
While there may be an opportunity to buy in 2's I will certainly look to accumulate anywhere under 2.8. Mark my words, once we have a clear winner through trial results, this will be a 10 bagger and the naysayers will be crying.
Once we achieve commercialisation, I expect a rerate to 25 times market cap would be on the cards.
DYOR, as the risk is still there, but no better time to punt.
EMS Price at posting:
3.1¢ Sentiment: Buy Disclosure: Held
